Immupharma PLC - pharmaceutical company - Says lender Lind Global Macro Fund LP has requested repayment of its part of convertible security. Immupharma repays USD1.1 million, with USD355.113 outstanding. "Following the repayment the company still expects to have sufficient cash resources to fund operations through the end of 2023," Immupharma said.
Current stock price: 11.25 pence
Year-to-date change: down 30%
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
Immupharma (IMM)